This is a preview of subscription content, log in via an institution to check access.
Notes
Ceregene is a majority-owned subsidiary of Cell Genesys, Inc.
References
CGRP Antagonists — New Drug Class for Migraine?
New England Journal of Medicine 2004; 350 (11): 1104–1110
New England Journal of Medicine 2004; 350 (11): 1073–1075
Antibacterials May Become Orphan Drugs
Science 2004; 303 (5665): 1798
Rights and permissions
About this article
Cite this article
Recent R&D Highlights. Pharmaceutical & Diagnostic Innovation 2, 26–27 (2004). https://doi.org/10.1007/BF03257293
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03257293